secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2025-01-08T23:59:59+00:00
Accession:  0001213900-25-002071
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharma raises ~$3M in registered direct offering of stock and warrants
-----------------------------------------------------------------------------

- Offering of 743,496 shares plus warrants for 743,496 shares at combined price of $4.035 per unit.
- Warrants exercisable at $4.035/share (8-K) or $3.91/share (press release), expire in 5 years.
- Net proceeds ~$2.7M after fees; intended for clinical development and working capital.
- H.C. Wainwright placement agent with 7% cash fee, $50k legal, $35k expense, and 52,045 placement agent warrants at $5.0438.
- Offering closed January 8, 2025 under effective shelf registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025002071/0001213900-25-002071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390025002071/ea0227130-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-002071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer